standard life and aviva clash over adviser charging
.
.
.
"i can't think of anything else where we have done that medically," van den veyver said.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.